{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:20Z","timestamp":1791489680203,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":264,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101455","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:39:42Z","timestamp":1790264382000},"page":"101455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Additive local radical therapy in synchronous oligometastatic non\u2013small cell lung cancer without oncogenic drivers: a single-center retrospective cohort study"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0628-9534","authenticated-orcid":false,"given":"Maximilian Daniel","family":"A\u00dfmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius Helmut","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dr\u00f6mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bohnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas F.","family":"Franzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2026.101455_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101455_bib0002","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jtho.2019.07.025","article-title":"Definition of synchronous oligometastatic non\u2013small cell lung cancer\u2014a consensus report","volume":"14","author":"Dingemans","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101455_bib0003","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/cancers16061174","article-title":"Long-term survival in patients with oligometastatic non-small cell lung cancer by a multimodality treatment\u2014comparison with stage III disease","volume":"16","author":"Guberina","year":"2024","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101455_bib0004","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol."},{"issue":"18","key":"10.1016\/j.ctarc.2026.101455_bib0005","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101455_bib0006","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.lungcan.2018.09.021","article-title":"Local ablative treatment for synchronous single organ oligometastatic lung cancer\u2014a propensity score analysis of 180 patients","volume":"125","author":"Frost","year":"2018","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101455_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non\u2013small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101455_bib0008","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamaoncol.2019.1478","article-title":"Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non\u2013small cell lung cancer: results of the PEMBRO-RT phase 2 randomized clinical trial","volume":"5","author":"Theelen","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ctarc.2026.101455_bib0009","doi-asserted-by":"crossref","unstructured":"Palma D.A., Olson R., Harrow S., Gaede S., Louie A.V., Haasbeek C., et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051\u20138. doi:10.1016\/S0140-6736(18)32487-5.","DOI":"10.1016\/S0140-6736(18)32487-5"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101455_bib0010","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/1759-7714.14312","article-title":"Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: a retrospective observational study","volume":"13","author":"Chen","year":"2022","journal-title":"Thorac. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101455_bib0011","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.cllc.2016.06.011","article-title":"Patterns of distant metastases after surgical management of non\u2013small-cell lung cancer","volume":"18","author":"Torok","year":"2017","journal-title":"Clin. Lung Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101455_bib0012","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","article-title":"Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer","volume":"89","author":"Parikh","year":"2014","journal-title":"Int. J. Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101455_bib0013","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non\u2013small-cell lung cancer","volume":"15","author":"Ashworth","year":"2014","journal-title":"Clin. Lung Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101455_bib0014","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","article-title":"Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101455_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non\u2013small cell lung cancer, version 3.2022, NCCN Clinical Practice Guidelines In Oncology","volume":"20","author":"Ettinger","year":"2022","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ctarc.2026.101455_bib0016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejca.2019.09.012","article-title":"EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease","volume":"122","author":"Levy","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101455_bib0017","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101455_bib0018","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.21037\/tlcr-20-994","article-title":"Local ablative therapies in oligometastatic NSCLC-upfront or outback?\u2014a narrative review","volume":"10","author":"Tjong","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101455_bib0019","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ijc.35199","article-title":"Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome","volume":"156","author":"Wiesweg","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"16_suppl","key":"10.1016\/j.ctarc.2026.101455_bib0020","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.8506","article-title":"NRG-LU002: Randomized phase II\/III trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC)","volume":"42","author":"Iyengar","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101455_bib0021","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jtho.2022.09.227","article-title":"Local treatments of oligometastatic and oligoprogressive NSCLC should not become the standard of care","volume":"18","author":"Macbeth","year":"2023","journal-title":"J. Thorac. Oncol."},{"issue":"1157","key":"10.1016\/j.ctarc.2026.101455_bib0022","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/bjr\/tqae068","article-title":"Is it too early to recommend local treatment in oligometastatic non-small cell lung cancer: a plea for equipoise","volume":"97","author":"Ahmad","year":"2024","journal-title":"Br. J. Radiol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101455_bib0023","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.21037\/tlcr-20-982","article-title":"Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis","volume":"10","author":"Gobbini","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101455_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107848","article-title":"Evaluation of chest CT-scans following lung stereotactic ablative radiotherapy: challenges and new insights","volume":"193","author":"De Bruycker","year":"2024","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101455_bib0025","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/JTO.0b013e3182745948","article-title":"Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non\u2013small-cell lung cancer","volume":"7","author":"Weickhardt","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101455_bib0026","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.prro.2023.04.004","article-title":"Treatment of oligometastatic non-small cell lung cancer: an ASTRO\/ESTRO clinical practice guideline","volume":"13","author":"Iyengar","year":"2023","journal-title":"Pract. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101455_bib0027","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijrobp.2024.05.015","article-title":"Local ablative therapy combined with pembrolizumab in patients with synchronous oligometastatic non-small cell lung cancer: a recursive partitioning analysis","volume":"120","author":"Lee","year":"2024","journal-title":"Int. J. Radiat. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101455_bib0028","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1007\/s11999-008-0346-9","article-title":"Statistics in brief: the importance of sample size in the planning and interpretation of medical research","volume":"466","author":"Biau","year":"2008","journal-title":"Clin. Orthop."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:42:57Z","timestamp":1791488577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":28,"alternative-id":["S2468294226003655"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101455","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additive local radical therapy in synchronous oligometastatic non\u2013small cell lung cancer without oncogenic drivers: a single-center retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101455"}}